Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Cogent Biosciences Inc (COGT)

317 + Investors. Track Smart Money conviction in COGT. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +16
Streak
4Q ▲
Buyers last Q
60%

Smart Money Signals — COGT

Based on 321 hedge funds · latest filing: 2026 Q2 · updated quarterly

📈

Buying streak — 4 quarters in a row

last 6Q
For 4 consecutive quarters, more hedge funds added COGT than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
321 hedge funds hold COGT right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +79% more funds vs a year ago

fund count last 6Q
+142 new funds entered over the past year (+79% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟢

More buyers than sellers — 60% buying

205 buying138 selling
Last quarter: 205 funds were net buyers (67 opened a brand new position + 138 added to an existing one). Only 138 were sellers (87 trimmed + 51 sold completely). A clear majority buying is a strong confirmation signal.
⚠️

Fewer new buyers each quarter (-10 vs last Q)

new funds entering per quarter
Funds opening this position for the first time: 40 → 97 → 77 → 67. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.
🔒

40% of holders stayed for 2+ years

■ 40% conviction (2yr+) ■ 22% medium ■ 39% new
127 out of 321 hedge funds have held COGT for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
➡️

Steady discovery — ~67 new funds/quarter

30 → 40 → 97 → 77 → 67 new funds/Q
New funds entering each quarter: 40 → 97 → 77 → 67. Consistent flow of new institutional buyers without clear acceleration or slowdown.
🏛️

Veteran-anchored — 49% veterans vs 40% newcomers

■ 49% veterans ■ 11% 1-2yr ■ 40% new
Entry-cohort mix of 328 holders: 162 (49%) are 2+ year veterans, 35 entered 1–2 years ago, and 131 (40%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
🏆

Elite ownership — 45% AUM from top-100 funds

45% from top-100 AUM funds
54 of 317 holders are among the 100 largest funds by AUM, controlling 45% of total institutional value in COGT. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
4.9
out of 10
Moderate Exit Risk
Exit risk score 4.9/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — COGT

In 2026 Q2, 205 hedge funds were net buyers of COGT (67 opened a new position, 138 added to an existing one), while 138 reduced or exited (87 trimmed, 51 sold completely) — a 60% buyer ratio, indicating clear institutional accumulation. This marks 4 consecutive quarters of net institutional buying — a persistent conviction signal. 45% of total institutional value in COGT is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: +16 funds (more new holders than closures). Total institutional holders: 321.

Hedge Fund Ownership: COGT

How many hedge funds hold COGT — quarterly history vs. share price
Quarterly hedge fund ownership of COGT vs. share price

Market Analysis: COGT

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: COGT

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Cogent Biosciences Inc (COGT) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much COGT has moved relative to its sector benchmark (XLV) since the 2026 Q2 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End June 30, 2026 · 51d ago
COGT
-3.4%
XLV
+9.7%

COGT outperformed XLV by -13.1% since June 30, 2026.

Since 13F Filing Date August 14, 2026 · 6d ago
COGT
-1.4%
XLV
+4.0%

Since the filing became public, COGT outperformed XLV by -5.4% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

19 top-rated funds 20 high-conviction
Consensus
5.6
/ 10
breadth
×
Elite
5.3
/ 10
conviction
Hedge Fund Positioning: COGT
317 + Investors

Track Smart Money conviction in COGT. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q2) Prior (2026 Q1) Change
Funds Holding 317 305 3.93%
13F Shares 195M 187M 4.09%
Total Value $7.20B $6.94B 3.7%
New Positions 67 77 -10
Increased Positions 134 119 +15
Closed Positions 51 40 +11
Reduced Positions 86 81 +5
Total Calls 6 6 -
Total Puts 5 6 -16.67%
PUT/CALL Ratio 0.83 1.0 Neutral

Statistics: COGT

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q2)

317 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in COGT. Verified SEC 13F-HR filings.

QUARTER:
Top 25 COGT holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Fairmount Funds Management LLC 14.08% 5,503,418 $213.0M
2 Elmind Capital, LP 11.38% 1,170,740 $45.3M
3 Squadron Capital Management LLC 10.39% 865,000 $33.5M
4 Superstring Capital Management LP 8.39% 343,284 $13.3M
5 Octagon Capital Advisors LP 8.17% 2,350,000 $90.9M
6 Kynam Capital Management, LP 7.84% 3,667,097 $141.9M
7 Commodore Capital LP 7.03% 3,050,000 $118.0M
8 Silverarc Capital Management, LLC 5.15% 1,280,707 $49.6M
9 Exome Asset Management LLC 5.03% 210,523 $8.1M
10 TCG Crossover Management, LLC 4.52% 4,854,436 $187.9M
11 Patient Square Capital LP 2.55% 425,000 $16.4M
12 First Turn Management, LLC 2.49% 602,281 $23.3M
13 Diadema Partners LP 2.41% 493,664 $19.1M
14 NEXTBio Capital Management LP 2.33% 131,075 $5.1M
15 Sphera Funds Management LTD. 2.32% 459,340 $17.8M
16 Knott David M Jr 2.27% 111,081 $4.3M
17 Sofinnova Investments, Inc. 2.07% 1,035,148 $40.1M
18 Defilade Capital Management, L.P. 2.04% 393,441 $15.2M
19 Deerfield Management Company, L.P. 2.02% 5,006,104 $193.7M
20 Venrock Adviser, LLC 1.93% 1,642,166 $63.6M
21 HighVista Strategies LLC 1.67% 188,780 $7.3M
22 Persistent Asset Partners Ltd 1.60% 138,272 $5.4M
23 Ikarian Capital, LLC 1.54% 370,084 $14.3M
24 Logos Global Management LP 1.50% 900,000 $34.8M
25 Platinum Investment Management Ltd 1.47% 154,220 $6.0M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Cogent Biosciences Inc (COGT)

What does the Smart Money Trend signal show for COGT?

Buying streak — 4 quarters in a row: For 4 consecutive quarters, more hedge funds added COGT than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for COGT?

More buyers than sellers — 60% buying: Last quarter: 205 funds were net buyers (67 opened a brand new position + 138 added to an existing one). Only 138 were sellers (87 trimmed + 51 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for COGT holders?

Elite ownership — 45% AUM from top-100 funds: 54 of 317 holders are among the 100 largest funds by AUM, controlling 45% of total institutional value in COGT. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held COGT?

40% of holders stayed for 2+ years: 127 out of 321 hedge funds have held COGT for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Cogent Biosciences Inc (COGT) following the 2026 Q2 hedge fund 13F filings?

As of today, COGT has moved -1.4% since the 2026 Q2 13F filing date (August 14, 2026), compared to +4.0% for the XLV sector ETF — an outperformance of -5.4%. Since the quarter end (June 30, 2026), COGT has gained -3.4% vs +9.7% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →